- Home
- UUUU vs BLTE Comparison
UUUU vs BLTE Comparison
Compare UUUU & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UUUU | BLTE |
|---|---|---|
| Founded | 1987 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 4.1B |
| IPO Year | 2006 | 2021 |
Fundamental Metrics
Financial Performance| Metric | UUUU | BLTE |
|---|---|---|
| Price | $20.07 | $173.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $19.92 | ★ $181.14 |
| AVG Volume (30 Days) | ★ 9.0M | 150.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $65,922,000.00 | N/A |
| Revenue This Year | $113.24 | N/A |
| Revenue Next Year | $36.77 | $218.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.20 | $49.00 |
| 52 Week High | $27.90 | $200.00 |
Technical Indicators
Market Signals| Indicator | UUUU | BLTE |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 48.54 |
| Support Level | $19.34 | $167.80 |
| Resistance Level | $23.61 | $174.78 |
| Average True Range (ATR) | 1.73 | 8.39 |
| MACD | -0.30 | -1.71 |
| Stochastic Oscillator | 25.96 | 26.53 |
Price Performance
Historical ComparisonAbout UUUU Energy Fuels Inc (Canada)
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.
About BLTE Belite Bio Inc
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.